Published in Epidemiol Rev on May 10, 2007
Quality of Recovery Scores in Parturients With Obesity | NCT04988893
Childhood obesity and adult morbidities. Am J Clin Nutr (2010) 3.80
Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes. PLoS One (2009) 1.87
Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetol Metab Syndr (2011) 1.15
Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity (Silver Spring) (2009) 1.14
Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease. Cardiovasc Diabetol (2014) 1.01
Epidemiology of cytokines: the Women On the Move through Activity and Nutrition (WOMAN) Study. Am J Epidemiol (2008) 0.93
Associations between obesity and changes in adult BMI over time and colon cancer risk. Obesity (Silver Spring) (2008) 0.87
Onset of obesity in carboxypeptidase E-deficient mice and effect on airway responsiveness and pulmonary responses to ozone. J Appl Physiol (1985) (2010) 0.86
Effect of antigen sensitization and challenge on oscillatory mechanics of the lung and pulmonary inflammation in obese carboxypeptidase E-deficient mice. Am J Physiol Regul Integr Comp Physiol (2014) 0.85
Influences of the common FTO rs9939609 variant on inflammatory markers throughout a broad range of body mass index. PLoS One (2011) 0.85
Blood cell transcriptomic-based early biomarkers of adverse programming effects of gestational calorie restriction and their reversibility by leptin supplementation. Sci Rep (2015) 0.80
Circulating levels of adiponectin, leptin, fetuin-A and retinol-binding protein in patients with tuberculosis: markers of metabolism and inflammation. PLoS One (2012) 0.79
Fractional flow reserve is not associated with inflammatory markers in patients with stable coronary artery disease. PLoS One (2012) 0.78
Haplotypes in the CRP gene associated with increased BMI and levels of CRP in subjects with type 2 diabetes or obesity from Southwestern Mexico. Exp Diabetes Res (2012) 0.77
Cardiac autonomic dysfunction in obese normotensive children and adolescents. Rev Paul Pediatr (2014) 0.77
The 60- and 70-kDa heat-shock proteins and their correlation with cardiovascular risk factors in postmenopausal women with metabolic syndrome. Cell Stress Chaperones (2013) 0.76
Neutrophil/lymphocyte ratio in obese adolescents. North Clin Istanb (2015) 0.75
Inverse associations between androgens and renal function: the Young Men Cardiovascular Association (YMCA) study. Am J Hypertens (2008) 0.75
Positive influence of being overweight/obese on long term survival in patients hospitalised due to acute heart failure. PLoS One (2015) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51
The hormone resistin links obesity to diabetes. Nature (2001) 15.49
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem (1995) 13.34
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
Years of life lost due to obesity. JAMA (2003) 12.18
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res (2000) 10.95
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell (1999) 10.08
A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem (1995) 9.72
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest (1995) 9.59
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab (2001) 9.53
Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol (2003) 9.30
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science (1996) 8.57
A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet (1998) 8.02
PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell (1999) 7.56
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation (2000) 6.96
AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem (1996) 6.93
Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest (1991) 6.50
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet (1996) 6.48
Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 6.06
Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol (2002) 5.97
Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab (1997) 5.84
Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr (2001) 5.67
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med (1995) 5.24
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol (2003) 4.86
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology (2004) 4.67
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med (1989) 4.64
Interleukin-6-deficient mice develop mature-onset obesity. Nat Med (2002) 4.47
Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation (2005) 4.17
Structures of complement component C3 provide insights into the function and evolution of immunity. Nature (2005) 4.01
Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol (2003) 3.89
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem (2003) 3.57
Resistin is an inflammatory marker of atherosclerosis in humans. Circulation (2005) 3.52
Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol (2003) 3.40
Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes (2003) 3.29
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest (1999) 3.21
Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol (2005) 3.15
From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes (2004) 3.13
Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem (2002) 3.05
Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes (2003) 3.00
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract (2004) 2.95
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92
Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab (2000) 2.88
Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med (2003) 2.87
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med (2006) 2.86
Isoprostanes: markers and mediators of oxidative stress. FASEB J (2004) 2.83
Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J (2004) 2.82
Interleukin-18. J Leukoc Biol (2003) 2.75
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab (2001) 2.73
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation (2004) 2.58
Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr (2006) 2.47
Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol (2001) 2.44
Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2006) 2.40
Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab (2003) 2.39
Does central obesity reflect "Cushing's disease of the omentum"? Lancet (1997) 2.34
Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem (2001) 2.33
Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med (2000) 2.32
Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation (1998) 2.32
Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation (2002) 2.30
Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol (2004) 2.27
Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2003) 2.26
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet (1987) 2.23
Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation (2004) 2.20
Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol (2005) 2.17
Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol (2003) 2.04
Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia (2005) 2.03
Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes (2004) 2.03
Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med (1998) 1.93
Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res (2001) 1.89
Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int (2006) 1.87
Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res (2002) 1.86
Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes (2004) 1.85
Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA (2002) 1.83
The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab (2001) 1.77
TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest (2004) 1.76
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A (1992) 1.76
Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord (2004) 1.76
Complete absence of the third component of complement in man. J Clin Invest (1975) 1.75
Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2006) 1.69
Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology (2005) 1.68
Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res (2004) 1.68
A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation (1995) 1.66
Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol (2004) 1.64
Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy (2001) 1.62
Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes (1997) 1.60
Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol (2006) 1.58
Correlates of markers of oxidative status in the general population. Am J Epidemiol (2001) 1.56
Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab (2002) 1.56
Clinical and translational scientist career success: metrics for evaluation. Clin Transl Sci (2012) 1.61
Lab-on-a-chip sensor for detection of highly electronegative heavy metals by anodic stripping voltammetry. Biomed Microdevices (2011) 1.17
Altered myelination and axonal integrity in adults with childhood lead exposure: a diffusion tensor imaging study. Neurotoxicology (2009) 1.09
NIH grant awards as a metric of clinical and translational research training effectiveness. Clin Transl Sci (2014) 0.83
Publication track records as a metric of clinical research training effectiveness. Clin Transl Sci (2013) 0.83
Incorporating genetics and genomics in risk assessment for inhaled manganese: from data to policy. Neurotoxicology (2009) 0.82
Perceptions of genetic research in three rural Appalachian Ohio communities. J Community Genet (2012) 0.81
Copper-based electrochemical sensor with palladium electrode for cathodic stripping voltammetry of manganese. Anal Chem (2014) 0.81
Exposure of firefighters to particulates and polycyclic aromatic hydrocarbons. J Occup Environ Hyg (2014) 0.79
Retraction of "Impact of Natural Gas Extraction on PAH Levels in Ambient Air". Environ Sci Technol (2016) 0.77
Determination of Lead with a Copper-Based Electrochemical Sensor. Anal Chem (2017) 0.75